JP2002515439A5 - - Google Patents

Download PDF

Info

Publication number
JP2002515439A5
JP2002515439A5 JP2000549264A JP2000549264A JP2002515439A5 JP 2002515439 A5 JP2002515439 A5 JP 2002515439A5 JP 2000549264 A JP2000549264 A JP 2000549264A JP 2000549264 A JP2000549264 A JP 2000549264A JP 2002515439 A5 JP2002515439 A5 JP 2002515439A5
Authority
JP
Japan
Prior art keywords
active ingredient
method described
liquid carrier
carrier
phosphocholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000549264A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515439A (ja
Filing date
Publication date
Priority claimed from DE19822509A external-priority patent/DE19822509A1/de
Application filed filed Critical
Publication of JP2002515439A publication Critical patent/JP2002515439A/ja
Publication of JP2002515439A5 publication Critical patent/JP2002515439A5/ja
Pending legal-status Critical Current

Links

JP2000549264A 1998-05-19 1999-05-11 脳腫瘍の治療のためのエーデルホシン Pending JP2002515439A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19822509A DE19822509A1 (de) 1998-05-19 1998-05-19 Edelfosin zur Behandlung von Hirntumoren
DE19822509.1 1998-05-19
PCT/EP1999/003241 WO1999059599A1 (de) 1998-05-19 1999-05-11 Edelfosin zur behandlung von hirntumoren

Publications (2)

Publication Number Publication Date
JP2002515439A JP2002515439A (ja) 2002-05-28
JP2002515439A5 true JP2002515439A5 (enExample) 2006-07-13

Family

ID=7868323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000549264A Pending JP2002515439A (ja) 1998-05-19 1999-05-11 脳腫瘍の治療のためのエーデルホシン

Country Status (6)

Country Link
US (1) US6514519B1 (enExample)
EP (1) EP1079838B1 (enExample)
JP (1) JP2002515439A (enExample)
AT (1) ATE223721T1 (enExample)
DE (2) DE19822509A1 (enExample)
WO (1) WO1999059599A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE226843T1 (de) * 1998-12-04 2002-11-15 Max Delbrueck Centrum Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
US7041302B2 (en) * 2001-01-09 2006-05-09 Biother Corporation Therapeutic modulation of the tumor inflammatory response
JP2008539721A (ja) * 2005-05-02 2008-11-20 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク アルツハイマー病の治療のためのホスホイノシチドモジュレーション
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
JP5773569B2 (ja) * 2006-11-10 2015-09-02 アルファプトーゼ ゲーエムベーハーＡｌｐｈａｐｔｏｓｅ Ｇｎｂｈ 受容体リガンド模倣体を検出する方法
EP2089401B1 (en) * 2006-11-10 2012-07-25 RadioProtect Alphaptose UG (haftungsbeschränkt) & Co. KG Use of tri-substituted glycerol compounds for the treatment of radiation injuries
ATE546133T1 (de) * 2006-11-10 2012-03-15 Alphaptose Gmbh Orale dosierform mit trisubstituierten glycerin- verbindungen
ES2391226T3 (es) * 2006-12-20 2012-11-22 Alphaptose Gmbh Forma farmacéutica tópica que comprende compuestos de glicerol tri-sustituido
RU2474427C2 (ru) 2006-12-20 2013-02-10 Универзитетсклиникум Хамбург-Эппендорф Применение тризамещенных соединений глицерина для лечения гематологических злокачественных опухолей
AU2008254328A1 (en) 2007-05-18 2008-11-27 The Johns Hopkins University A treatment simulator for brain diseases and method of use thereof
RU2382765C1 (ru) * 2008-10-24 2010-02-27 Государственное образовательное учреждение высшего профессионального образования "Московская государственная академия тонкой химической технологии имени М.В. Ломоносова" Rac-N,N-ДИМЕТИЛ-N-[2-(5-N',N'- ДИМЕТИЛАМИНОНАФТАЛЕН-1-СУЛЬФОНИЛОКСИ)ЭТИЛ]-N- {4-[(2-МЕТОКСИ-3-ОКТАДЕЦИЛОКСИ)ПРОП-1-ИЛОКСИКАРБОНИЛ]БУТИЛ} АММОНИЙИОДИД
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941009A1 (de) * 1989-12-12 1991-06-13 Medmark Pharma Gmbh Eliminierung von aktivierten lymphozyten
DE4000084A1 (de) * 1990-01-03 1991-07-04 Medmark Pharma Gmbh Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts)
US5925669A (en) * 1994-03-22 1999-07-20 Molecular/Structural Bio Technologies, Inc. Carrier compositions for anti-neoplastic drugs
WO1997035588A1 (en) * 1996-03-27 1997-10-02 Uab Research Foundation Novel uses of phospholipase c inhibitors

Similar Documents

Publication Publication Date Title
CA2190148A1 (en) Oral liquid alendronate formulations
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
JP2003504333A (ja) 必須脂肪酸およびホモシステイン低下剤を含有する製剤および栄養組成物
GEP20063895B (en) Platinum derivative pharmaceutical formulations
JP2002515439A5 (enExample)
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
JP2002524415A5 (enExample)
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
EP0270026A3 (en) Pharmaceutical preparation comprising vitamin b6
RU2004131214A (ru) Способы лечения когнитивных расстройств
TW200534852A (en) 4-methylpyrazole formulations for inhibiting ethanol intolerance
IT1314199B1 (it) Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
CA2474430A1 (en) A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
WO2005013935A3 (en) Composition for releasing a weak base for an extended period of time
WO1995022324A1 (en) Treatment of migraine headaches and formulations
WO2000026185A3 (en) Omeprazole solution and method of using same
JP2003002827A5 (enExample)
JP2001316293A5 (enExample)
JPH0680564A (ja) 抗色素沈着治療薬
RU2003106417A (ru) Применение комбинации витаминов для лечения первичных головных болей
WO2004050019A3 (en) Method and compositions for treating anxiety